SARC Restructuring

SARC Strategic Plan Mission

Given there is no successful structure in the US to provide platform to make progress in the diagnosis and treatment of sarcoma, SARC exists to fill that void

Vision/Future picture of success Bring to the public new and effective therapies that will reduce

pain and suffering for sarcoma patients Provide stimulus for the recruitment and training of the brightest

and best clinician scientists to choose to study sarcoma in the future

Through collaboration and pooling of intellect, identify new and effective therapies

Establish SARC as the academic “voice” of sarcoma expertise Provide stimulus and infrastructure for exchange of ideas

SARCOrganization Chart

Board of Directors:Chairman of the BoardFinance

Committee:Treasurer

Executive Committee:President/Chief Operating Officer

Committees Medical Officer Operations Office• Career Development• Developmental Therapeutics• Participants• SPORE

Participation Committee

Suzanne George, MD Chair

Committee Members Paul Meyer, MD Margaret von Mehren, MD

SARC Participation

Criteria Membership in CTOS Site Principal Investigator 80 or more new cases per year Annual review/renewal

SARC Medical Officer

Medical Officer role Coordinate review of new concepts, protocols,

and manuscripts Chair monthly review of all ongoing studies Respond to specific medical inquiries

Oversight of safety Resource to project managers at SARC Work with study PIs

Clinical Trial Concept New study proposal

Submit to Medical Officer SARC to post format at website

Process for review Medical officer to present to Executive Committee for

consideration in relation to strategic direction Approved concepts/protocol development

SARC protocol template Medical officer and SARC operations staff support